
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1053 | 1053 | 993 | 1073 | 1674 | 2160 |
Fund Return | 5.3% | 5.3% | -0.71% | 2.39% | 10.85% | 8.01% |
Place in category | 10 | 10 | 25 | 60 | 26 | 18 |
% in Category | 9 | 9 | 20 | 33 | 18 | 18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JNL/Mellon Capital SP 500 Index Fua | 13.85B | -4.39 | 8.52 | 11.93 | ||
JNL/T Rowe Price Capital Appreciati | 13.15B | -0.36 | 6.34 | 9.72 | ||
JNL/WMC Balanced Fund Class A | 8.33B | -1.84 | 5.21 | 7.31 | ||
JNL/Mellon Capital Nasdaq 100 Funda | 7.04B | -8.22 | 9.35 | 16.13 | ||
JNL/American Funds Growth Fund | 6.07B | -7.21 | 8.85 | 14.87 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 34.63B | 0.63 | 2.20 | 6.39 | ||
T. Rowe Price Health Sciences | 6.8B | -0.04 | 0.26 | 7.27 | ||
Fidelity Select Health Care | 6.42B | -1.03 | 1.10 | 6.91 | ||
Vanguard Health Care Inv | 6.25B | 0.62 | 2.15 | 6.34 | ||
T. Rowe Price Health Sciences I | 4.79B | 0.00 | 0.39 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.99 | 732.41 | +1.60% | |
UnitedHealth | US91324P1021 | 8.27 | 599.47 | +0.85% | |
J&J | US4781601046 | 6.19 | 151.73 | +2.04% | |
AbbVie | US00287Y1091 | 5.58 | 175.05 | +0.49% | |
Merck&Co | US58933Y1055 | 4.52 | 79.18 | +2.10% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review